CORRECTION: Athenex to Provide Corporate and Financial Update for the Fourth Quarter and Full Year 2021, on March 16, 2022

BUFFALO, N.Y., March 14, 2022 -- Athenex , a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and... | March 14, 2022

Related Keywords

Daniel Lang ,Caileigh Dougherty ,Globenewswire Inc ,Athenex Inc , ,Investor Relations ,Oncology Innovation Platform ,Commercial Platform ,Global Supply Chain ,Athenex ,Nc Stock Exchange ,News ,Information ,Press Release ,Arch ,022 ,Lobal ,Iopharmaceutical ,Company ,Edicated ,O ,The ,End ,Ommercialization ,F ,Novel ,Therapies ,Or ,Treatment ,Ancer Atnx Us04685n1037 ,